McGrath P J, Quitkin F M, Stewart J W, Asnis G, Novacenko H, Puig-Antich J
Psychiatry Res. 1984 Jul;12(3):185-93. doi: 10.1016/0165-1781(84)90024-6.
The pituitary thyroid-stimulating hormone (TSH) response to exogenous thyrotropin-releasing hormone (TRH) has been reported abnormal in depression, chiefly in endogenous depression among inpatients. This study finds an incidence of abnormality among a group of 53 outpatients that is no greater than among controls. Among outpatients with either major depression by Research Diagnostic Criteria (RDC) or atypical depression by our criteria, blunted responses are no more common than among normal controls. A comparison group of inpatient RDC major depressives, endogenous subtype, shows a significantly higher proportion of abnormal or blunted responses. These data suggest that the test may be less useful among outpatients than among inpatients. The test does detect a significant but unexplained biologic abnormality among inpatient endogenous depressives.
据报道,垂体促甲状腺激素(TSH)对外源性促甲状腺激素释放激素(TRH)的反应在抑郁症患者中异常,主要是住院患者中的内源性抑郁症患者。本研究发现,一组53名门诊患者的异常发生率并不高于对照组。在符合研究诊断标准(RDC)的重度抑郁症门诊患者或符合我们标准的非典型抑郁症门诊患者中,反应迟钝并不比正常对照组更常见。一组住院的RDC重度抑郁症患者(内源性亚型)显示,异常或反应迟钝的比例显著更高。这些数据表明,该测试在门诊患者中可能不如在住院患者中有用。该测试确实在住院内源性抑郁症患者中检测到了一种显著但无法解释的生物学异常。